Net margin is calculated as Net Income divided by its Revenue. Motus GI Holdings's Net Income for the
three
months ended in Dec. 2023 was $-2.81 Mil. Motus GI Holdings's Revenue for the
three
months ended in Dec. 2023 was $0.06 Mil. Therefore, Motus GI Holdings's net margin for the quarter that ended in Dec. 2023 was -4,382.81%.
The historical rank and industry rank for Motus GI Holdings's Net Margin % or its related term are showing as below:
MOTS'
s Net Margin % Range Over the Past 10 Years
Min: -61825 Med: -12258.89 Max: -3141.39
Current: -4033.54
MOTS's Net Margin % is ranked worse than 96.2% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 0.045
vs MOTS: -4033.54
Motus GI Holdings Net Margin % Historical Data
The historical data trend for Motus GI Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Motus GI Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Motus GI Holdings Net Margin % Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Motus GI Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Motus GI Holdings's Net Margin % falls into.
Motus GI Holdings Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Motus GI Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Motus GI Holdings (OTCPK:MOTS) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Motus GI Holdings Net Margin % Related Terms
Thank you for viewing the detailed overview of Motus GI Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Motus GI Holdings (Motus GI Holdings) Business Description
Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the "FDA") to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal ("GI") endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MOTS has been successfully added to your 